Company has reported strong momentum among the early-stage businesses it invested in last year

Research concerning candidate VLA15 has been discontinued across certain trial sites

Updated Date: Thu, 09 Feb 2023 00:00:00 EST

Updated Date: Thu, 09 Feb 2023 00:00:00 EST

Updated Date: Thu, 09 Feb 2023 00:00:00 EST

Updated Date: Thu, 09 Feb 2023 00:00:00 EST

Updated Date: Thu, 09 Feb 2023 00:00:00 EST

Psychostimulants interacting with the dopamine transporter are found in the therapy of neuro-psychiatric disorders, such as ADHD or […]

First subject dosed with company’s SPL028 – a proprietary deuterated DMT candidate

Advice concerns the use of COVID-19 vaccine when treating specific vulnerable individuals